Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.

Gullett NP, Hebbar G, Ziegler TR.

Am J Clin Nutr. 2010 Apr;91(4):1143S-1147S. doi: 10.3945/ajcn.2010.28608E. Epub 2010 Feb 17. Review.

2.

Ghrelin: from discovery to cancer cachexia therapy.

Molfino A, Formiconi A, Rossi Fanelli F, Muscaritoli M.

Curr Opin Clin Nutr Metab Care. 2014 Sep;17(5):471-6. doi: 10.1097/MCO.0000000000000075. Review.

PMID:
24905862
3.

Approved pharmacologic interventions for wasting: an overview and lessons learned.

Mann M.

J Nutr. 1999 Jan;129(1S Suppl):303S-305S. No abstract available.

4.

A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.

Argil├ęs JM, Anguera A, Stemmler B.

Clin Nutr. 2013 Jun;32(3):319-24. doi: 10.1016/j.clnu.2013.01.004. Epub 2013 Jan 22. Review.

PMID:
23395103
5.

Clinical trials update in human immunodeficiency virus wasting.

Muurahainen N, Mulligan K.

Semin Oncol. 1998 Apr;25(2 Suppl 6):104-11. Review.

PMID:
9625392
6.

The role of ghrelin and ghrelin analogues in wasting disease.

Kamiji MM, Inui A.

Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):443-51. doi: 10.1097/MCO.0b013e328303dee4. Review.

PMID:
18542005
7.

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.

Mulligan K, Schambelan M.

Int J Cardiol. 2002 Sep;85(1):151-9. Review.

PMID:
12163220
8.

Mechanism and novel therapeutic approaches to wasting in chronic disease.

Ebner N, Springer J, Kalantar-Zadeh K, Lainscak M, Doehner W, Anker SD, von Haehling S.

Maturitas. 2013 Jul;75(3):199-206. doi: 10.1016/j.maturitas.2013.03.014. Epub 2013 May 9. Review.

PMID:
23664695
9.

Approaches to the AIDS Wasting Syndrome.

Corcoran C.

Posit Dir News. 1998 Summer;10(2):24-7. English, Spanish.

PMID:
11365549
10.

Acylated and unacylated ghrelin administration to blunt muscle wasting.

Reano S, Graziani A, Filigheddu N.

Curr Opin Clin Nutr Metab Care. 2014 May;17(3):236-40. doi: 10.1097/MCO.0000000000000049. Review.

PMID:
24572833
11.
12.

Anabolic steroids.

[No authors listed]

Treat Rev. 1995 May;(no 18):8.

PMID:
11362596
13.

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

Dalton JT, Taylor RP, Mohler ML, Steiner MS.

Curr Opin Support Palliat Care. 2013 Dec;7(4):345-51. doi: 10.1097/SPC.0000000000000015. Review.

PMID:
24189892
14.

The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.

Koopman R, Ryall JG, Church JE, Lynch GS.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):601-6. doi: 10.1097/MCO.0b013e3283318a25. Review.

PMID:
19741516
15.

Testosterone replacement, weight lifting help wasting.

[No authors listed]

AIDS Alert. 1996 Jun;11(6):suppl 1-2.

PMID:
11363546
16.

Treatment of cachexia: an overview of recent developments.

von Haehling S, Anker SD.

J Am Med Dir Assoc. 2014 Dec;15(12):866-72. doi: 10.1016/j.jamda.2014.09.007. Epub 2014 Nov 20. Review.

17.

Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.

von Haehling S, Stepney R, Anker SD.

Int J Cardiol. 2010 Oct 29;144(3):347-9. doi: 10.1016/j.ijcard.2010.05.042. Epub 2010 Jun 19.

PMID:
20561693
18.

Cardiac cachexia: a systematic overview.

von Haehling S, Lainscak M, Springer J, Anker SD.

Pharmacol Ther. 2009 Mar;121(3):227-52. doi: 10.1016/j.pharmthera.2008.09.009. Epub 2008 Nov 14. Review.

PMID:
19061914
19.

Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?

Sakkas GK, Schambelan M, Mulligan K.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):623-7. doi: 10.1097/MCO.0b013e328331de63. Review.

20.

Anorexia/cachexia in patients with HIV: lessons for the oncologist.

Von Roenn JH, Knopf K.

Oncology (Williston Park). 1996 Jul;10(7):1049-56; discussion 1062-4, 1067-8. Review.

Supplemental Content

Support Center